| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |